Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1981 Feb 1;153(2):235–244. doi: 10.1084/jem.153.2.235

Plasmacytic differentiation of circulating Epstein-Barr virus-infected B lymphocytes during acute infectious mononucleosis

PMCID: PMC2186087  PMID: 6264016

Abstract

During the acute phase (1 wk of symptoms or less) of infectious mononucleosis (IM), 70--80% of circulating Epstein-Barr virus nuclear antigen (EBNA)-positive cells have differentiated toward plasma cells. Thus the characteristics of the infected cells in the majority of IM patients during early disease are indistinguishable from EBNA-positive tumor cells of a previously reported child who developed lymphoma during IM. IgA and IgG were the most frequent and IgM the least frequent immunoglobulin isotypes detected in EBNA-positive cells. In acute disease EBNA was present in 5.5--20% of T cell-depleted blood lymphocytes but in the 2nd or 3rd wk of illness the number of EBNA- positive cells sharply decreased to 0.4--1.4%. At the same time the fraction of antigen-positive cells containing cytoplasmic immunoglobulins also diminished, suggesting either that differentiation of infected cells was altered during the disease or that nondifferentiated antigen-positive cells had a survival advantage. Both the high proportion of plasmacytic EBNA-positive cells seen during acute disease and the apparent loss of differentiation by these cells later in disease may be regulated by host immunologic factors. Immunoglobulin-producing EBNA-positive cells may be the source of heterophile antibodies and other seemingly inappropriate antibodies usually found in serum during IM; however, increased numbers of noninfected plasma cells were present in some patients and may also be a potential source of these unusual antibodies.

Full Text

The Full Text of this article is available as a PDF (806.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bird A. G., Britton S. A new approach to the study of human B lymphocyte function using an indirect plaque assay and a direct B cell activator. Immunol Rev. 1979;45:41–67. doi: 10.1111/j.1600-065x.1979.tb00272.x. [DOI] [PubMed] [Google Scholar]
  2. Chiorazzi N., Fu S. M., Kunkel H. G. Induction of human antibody responses in vitro with emphasis on allogeneic helper factors. Immunol Rev. 1979;45:219–241. doi: 10.1111/j.1600-065x.1979.tb00279.x. [DOI] [PubMed] [Google Scholar]
  3. Crawford D. H., Rickinson A. B., Finerty S., Epstein M. A. Epstein-Barr (EB) virus genome-containing, EB nuclear antigen-negative B-lymphocyte populations in blood in acute infectious mononucleosis. J Gen Virol. 1978 Mar;38(3):449–460. doi: 10.1099/0022-1317-38-3-449. [DOI] [PubMed] [Google Scholar]
  4. Diehl V., Henle G., Henle W., Kohn G. Demonstration of a herpes group virus in cultures of peripheral leukocytes from patients with infectious mononucleosis. J Virol. 1968 Jul;2(7):663–669. doi: 10.1128/jvi.2.7.663-669.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Giuliano V. J., Jasin H. E., Ziff M. The nature of the atypical lymphocyte in infectious mononucleosis. Clin Immunol Immunopathol. 1974 Sep;3(1):90–98. doi: 10.1016/0090-1229(74)90026-9. [DOI] [PubMed] [Google Scholar]
  6. Haynes B. F., Schooley R. T., Payling-Wright C. R., Grouse J. E., Dolin R., Fauci A. S. Emergence of suppressor cells of immunoglobulin synthesis during acute Epstein-Barr virus-induced infectious mononucleosis. J Immunol. 1979 Nov;123(5):2095–2101. [PubMed] [Google Scholar]
  7. Henderson E., Robinson J., Frank A., Miller G. Epstein-Barr virus: transformation of lymphocytes separated by size or exposed to bromodeoxyuridine and light. Virology. 1977 Oct 1;82(1):196–205. doi: 10.1016/0042-6822(77)90042-3. [DOI] [PubMed] [Google Scholar]
  8. Henle G., Henle W., Diehl V. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proc Natl Acad Sci U S A. 1968 Jan;59(1):94–101. doi: 10.1073/pnas.59.1.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hijmans W., Schuit H. R. Immunofluorescence studies on immunoglobulins in the lymphoid cells of human peripheral blood. Clin Exp Immunol. 1972 Aug;11(4):483–494. [PMC free article] [PubMed] [Google Scholar]
  10. Hutt L. M., Huang Y. T., Dascomb H. E., Pagano J. S. Enhanced destruction of lymphoid cell lines by peripheral blood leukocytes taken from patients with acute infectious mononucleosis. J Immunol. 1975 Jul;115(1):243–248. [PubMed] [Google Scholar]
  11. Jondal M., Klein G. Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes. J Exp Med. 1973 Dec 1;138(6):1365–1378. doi: 10.1084/jem.138.6.1365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jondal M., Pross H. Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations. Int J Cancer. 1975 Apr 15;15(4):596–605. doi: 10.1002/ijc.2910150409. [DOI] [PubMed] [Google Scholar]
  13. Katsuki T., Hinuma Y., Saito T., Yamamoto J., Hirashima Y., Sudoh H., Deguchi M., Motokawa M. Simultaneous presence of EBNA-positive and colony-forming cells in peripheral blood of patients with infectious mononucleosis. Int J Cancer. 1979 Jun 15;23(6):746–750. doi: 10.1002/ijc.2910230603. [DOI] [PubMed] [Google Scholar]
  14. Kirchner H., Tosato G., Blaese R. M., Broder S., Magrath I. T. Polyclonal immunoglobulin secretion by human B lymphocytes exposed to Epstein-Barr virus in vitro. J Immunol. 1979 Apr;122(4):1310–1313. [PubMed] [Google Scholar]
  15. Klein G. The Epstein-Barr virus and neoplasia. N Engl J Med. 1975 Dec 25;293(26):1353–1357. doi: 10.1056/NEJM197512252932607. [DOI] [PubMed] [Google Scholar]
  16. Langhorne J., Feizi T. Studies on the heterophile antibodies of infectious mononucleosis. I. Separation of four antibody populations, one of which contains lymphocytotoxic activity. Clin Exp Immunol. 1977 Dec;30(3):354–363. [PMC free article] [PubMed] [Google Scholar]
  17. Mogensen C. E. The glomerular permeability determined by dextran clearance using Sephadex gel filtration. Scand J Clin Lab Invest. 1968;21(1):77–82. doi: 10.3109/00365516809076979. [DOI] [PubMed] [Google Scholar]
  18. Morgan D. G., Niederman J. C., Miller G., Smith H. W., Dowaliby J. M. Site of Epstein-Barr virus replication in the oropharynx. Lancet. 1979 Dec 1;2(8153):1154–1157. doi: 10.1016/s0140-6736(79)92384-5. [DOI] [PubMed] [Google Scholar]
  19. Pope J. H., Horne M. K., Scott W. Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus. Int J Cancer. 1968 Nov 15;3(6):857–866. doi: 10.1002/ijc.2910030619. [DOI] [PubMed] [Google Scholar]
  20. Purtilo D. T., Szymanski I., Bhawan J., Yang J. P., Hutt L. M., Boto W., DeNicola L., Maier R., Thorley-Lawson D. Epstein-Barr virus infections in the X-linked recessive lymphoproliferative syndrome. Lancet. 1978 Apr 15;1(8068):798–801. doi: 10.1016/s0140-6736(78)92999-9. [DOI] [PubMed] [Google Scholar]
  21. Rickinson A. B., Jarvis J. E., Crawford D. H., Epstein M. A. Observations on the type of infection by Epstein-Barr virus in peripheral lymphoid cells of patients with infectious mononucleosis. Int J Cancer. 1974 Dec 15;14(6):704–715. doi: 10.1002/ijc.2910140603. [DOI] [PubMed] [Google Scholar]
  22. Robinson J. E., Brown N., Andiman W., Halliday K., Francke U., Robert M. F., Andersson-Anvret M., Horstmann D., Miller G. Diffuse polyclonal B-cell lymphoma during primary infection with Epstein-Barr virus. N Engl J Med. 1980 Jun 5;302(23):1293–1297. doi: 10.1056/NEJM198006053022306. [DOI] [PubMed] [Google Scholar]
  23. Robinson J., Smith D., Niederman J. Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis. Nature. 1980 Sep 25;287(5780):334–335. doi: 10.1038/287334a0. [DOI] [PubMed] [Google Scholar]
  24. Sheldon P. J., Hemsted E. H., Papamichail M., Holborow E. J. Thymic origin of atypical lymphoid cells in infectious mononucleosis. Lancet. 1973 May 26;1(7813):1153–1155. doi: 10.1016/s0140-6736(73)91148-3. [DOI] [PubMed] [Google Scholar]
  25. Svedmyr E., Jondal M. Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1622–1626. doi: 10.1073/pnas.72.4.1622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Thorley-Lawson D. A., Chess L., Strominger J. L. Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes. J Exp Med. 1977 Aug 1;146(2):495–508. doi: 10.1084/jem.146.2.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Tosato G., Magrath I., Koski I., Dooley N., Blaese M. Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis. N Engl J Med. 1979 Nov 22;301(21):1133–1137. doi: 10.1056/NEJM197911223012101. [DOI] [PubMed] [Google Scholar]
  28. Trinchieri G., Santoli D., Koprowski H. Spontaneous cell-mediated cytotoxicity in humans: role of interferon and immunoglobulins. J Immunol. 1978 Jun;120(6):1849–1855. [PubMed] [Google Scholar]
  29. Weiner M. S., Bianco C., Nussenzweig V. Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes. Blood. 1973 Dec;42(6):939–946. [PubMed] [Google Scholar]
  30. Wollheim F. A., Williams R. C., Jr Studies on the macroglobulins of human serum. I. Polyclonal immunoglobulin class M (IgM) increase in infectious mononucleosis. N Engl J Med. 1966 Jan 13;274(2):61–67. doi: 10.1056/NEJM196601132740202. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES